Pfizer Inc.

Industry: Major Drugs

Fortune Rank: 40

For the nine months ended 2 October 2005, Pfizer Inc.'s total revenues increased less than 1% to $37.71B. Net income from cont. ops. decreased 37% to $5.35B. Revenues reflect an increase in animal health pharmaceutical business segment. Net income was offset by the inclusion of merger-related in-process research and development charges of $1.39B, and an increase in restructuring charges and merger-related costs.

Pfizer Inc. (Pfizer) is a research-based, global pharmaceutical company. The Company discovers, develops, manufactures and markets prescription medicines for humans and animals, as well as consumer healthcare products. The Company operates in three business segments: Human Health (previously named Pharmaceutical), Consumer Healthcare and Animal Health. It also operates several other businesses, including the manufacture of empty soft-gelatin capsules, contract manufacturing and bulk pharmaceutical chemicals. Pfizer completed the acquisition of Esperion Therapeutics, Inc. on February 10, 2004. Esperion is a biopharmaceutical company focused on the development of high-density lipoprotein (HDL)-targeted (good cholesterol) therapies for the treatment of cardiovascular disease.

Pfizer Inc.

Pfizer Inc. is a Fortune 500 company. In 2010 Pfizer Inc. was ranked number 40 on the Fortune 500 list, making it the 40th largest company in the United States when judged by revenue.

Pfizer Inc. achieved revenue of $50,009.00 million in 2010 and earned a profit of $8,635.00 million.

Pfizer Inc.' rank improves

The company ranking improved in 2010, moving up the Fortune 500 list to 40th compared to 46th in 2009. This was based on its 2009 revenue of $48,296 million (a change of 2 million compared to 2010) and profits of $8,104 million (a change of $0 million compared to 2009).

Another point of view

To many investors, profits are more important than the revenue a company earns. If the Fortune 500 was ranked by profits instead of revenue then Pfizer Inc. would be ranked 15th rather than 40th due to its profits of $8,635 in 2010.

Pfizer Inc. Revenue* Profit* Fortune Ranking

* US$ Million

USPages Latest Business News At A Glance Business Shortcuts